Ameriprise Financial Inc Assembly Biosciences, Inc. Transaction History

Ameriprise Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.46 - $2.45 $2,978 - $4,998	-2,040 Reduced 16.74%	10,145 $21,000
Q4 2021 Feb 14, 2022	SELL	$2.13 - $3.46 $5,197 - $8,442	-2,440 Reduced 16.68%	12,185 $28,000
Q3 2021 Nov 15, 2021	SELL	$3.14 - $3.9 $3,768 - $4,680	-1,200 Reduced 7.58%	14,625 $51,000
Q2 2021 Aug 16, 2021	SELL	$3.8 - $4.56 $4,313 - $5,175	-1,135 Reduced 6.69%	15,825 $61,000
Q1 2021 May 17, 2021	BUY	$4.33 - $6.63 $24,655 - $37,751	5,694 Added 50.54%	16,960 $78,000

Q4 2020 Feb 12, 2021	BUY	$4.87 - $17.29 $54,865 - $194,789	11,266 New	11,266 $69,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $665M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.